Navigation Links
Review of Takeda's Febuxostat New Drug Application Continues Past PDUFA Date
Date:1/18/2009

FDA has not completed routine investigator site and CRO vendor inspections

OSAKA, Japan, Jan. 19 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") today announced that Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary, received notification from the U.S. Food and Drug Administration (FDA) that FDA will not be able to complete its review of the febuxostat New Drug Application (NDA) by the Prescription Drug User Fee Act (PDUFA) date of January 18, 2009.

"The FDA raised no issues with the NDA submission or the data included in it, rather FDA stated that due to its inability to complete routine inspections at investigator sites and at a Clinical Research Organization vendor involved in the development of febuxostat, the PDUFA date for febuxostat would be missed by the FDA," said Dean Sundberg, senior vice president, regulatory affairs at Takeda Global Research & Development Center, Inc. "Takeda has taken all necessary steps and provided all necessary information at this point in the NDA review process and we await FDA's completion of these routine inspections and look forward to receiving a final approval date for febuxostat."

Febuxostat is currently under review with FDA for once-daily, oral treatment of hyperuricemia in patients with gout. The NDA for febuxostat included data from multiple clinical trials involving more than 4,000 patients. In November 2008, FDA's Arthritis Advisory Committee recommended febuxostat for approval by a vote of 12-0 with one panel member abstaining. Takeda licensed febuxostat from Teijin Pharma Limited (Teijin Pharma), based in Tokyo, Japan.

About Takeda Pharmaceutical Company Limited

Located in Osaka, Japan, Takeda (TSE: 4502) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leade
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. New review suggests caution on drugs to raise good cholesterol
2. Virginia Tech Review Panel Calls For Reform of Mental Health Treatment Law
3. Arbios Systems, Incs Q2/07 Analyst Review Issued by Scimitar Equity Research, Inc.
4. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
5. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
6. Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning
7. InstaCare Corp. Reviewing M&A Plans
8. CCF Reviews Contents of SCHIP Reauthorization Bill Legislation Places SCHIP on Solid Path
9. Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Managements Internal Control Review Efforts and on Legal Proceedings
10. Multicountry review shows that Bug Buster Kits reduce head lice and social stigma
11. MaxLife Fund Corp. retains the Law firm, Anslow & Jaclin, LLP of Manalapan, N.J., to review MaxLife Fund Corp. options to be listed on the NASDAQ Capital Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... today announced a new web-based, big data methodology ... platform, the Human Cognition Project , contains ... human cognitive performance, which currently includes more than ... up to 6 years. The study, published today ... Neuroscience , examined how Lumosity,s dataset can ...
(Date:6/20/2013)... Worldwide Power Products (WPP), a power-generation equipment provider ... its rental fleet of portable generators by ... rental market will enable the company to support more ... tropical weather event. , "With officials at NOAA [the ... Atlantic hurricane season could possibly be 'extremely active,' we ...
(Date:6/20/2013)... (PRWEB) June 20, 2013 ERT, ... safety and efficacy endpoint data collection, today announced ... assessment system. Having already been used by over ... in both audio (phone) and visual (web/tablet) patient ... biopharmaceutical products. , Having captured over 100,000 assessments ...
(Date:6/20/2013)... 2013 This comprehensive report ... on the oral and injectable formulations of ... the various formulation technologies involved in making ... of specific technologies. Wherever possible, marketed drugs ... as proof of validation along with the ...
(Date:6/20/2013)... (PRWEB) June 20, 2013 Presenting ... Rhinoplasty Society, society president and keynote speaker ... present and future of rhinoplasty (plastic surgery of ... the city from across the nation. In his ... closed-technique non-individualized rhinoplasty to current open-technique rhinoplasty that ...
Breaking Medicine News(10 mins):Health News:Lumosity's big data provides new approach to understanding human cognition 2Health News:Lumosity's big data provides new approach to understanding human cognition 3Health News:Worldwide Power Products Expands Its Rental Generator Inventory by $1 Million to Support Its Hurricane Season Response Program 2Health News:ERT Announces AVERT™ for Suicide Risk Assessment in Clinical Development 2Health News:ERT Announces AVERT™ for Suicide Risk Assessment in Clinical Development 3Health News:Novel Drug Delivery Systems Market (NDDS): Formulations (Oral & Injectable) Analysis in Research Report at RnRMarketResearch.com 2Health News:Novel Drug Delivery Systems Market (NDDS): Formulations (Oral & Injectable) Analysis in Research Report at RnRMarketResearch.com 3Health News:Novel Drug Delivery Systems Market (NDDS): Formulations (Oral & Injectable) Analysis in Research Report at RnRMarketResearch.com 4Health News:Dr. Rod J. Rohrich Delivers Keynote Address on the Future of Rhinoplasty 2Health News:Dr. Rod J. Rohrich Delivers Keynote Address on the Future of Rhinoplasty 3Health News:Dr. Rod J. Rohrich Delivers Keynote Address on the Future of Rhinoplasty 4
... after the death of a loved one can provide much-needed ... a study in the April issue of the Journal ... lost a relative to cancer took part in the study. ... included widows, widowers, daughters and sisters. Nine chose foot massage, ...
... Organic ... how well the product works. This Herbal Tea can be purchased at Youmeandtea.com, , ... (PRWEB) March 24, 2010 -- ... on how well the product works. This Herbal Tea can be purchased at Youmeandtea.com , ...
... ... stem childhood obesity and empower kids to make healthy decisions. , ... (Vocus) March 24, 2010 -- To help kids to ... KidPower Program, www.mvpkidpower.com on Facebook., , , , ,“Being on Facebook enables KidPower ...
... U.S. expert says screening is best way to prevent breast ... women for breast cancer does not appear to increase overall ... increased survival rates may instead be due to controlling risk ... is not as good as we hoped years ago," said ...
... ... your interview. One Portland, Oregon business is providing support—literally—for today’s job seekers. , ... (PRWEB) March 24, 2010 ... today announced a special discount offer for those seeking employment and looking for an ...
... ... offers conducive environment for company growth , ... Edmonton, AB (PRWEB) March 24, 2010 -- Edmonton Research Park ... ingredients and advanced manufacturing techniques. Although herbal remedies have been used around the world ...
Cached Medicine News:Health News:Hand and feet massages provide consolation for bereaved relatives 2Health News:Snoring Reduced With Relaxation Tea… Could It Be? 2Health News:Snoring Reduced With Relaxation Tea… Could It Be? 3Health News:MVP Health Care Takes KidPower Youth Sports Program to Facebook 2Health News:Mammograms May Not Boost Survival, Danish Study Suggests 2Health News:Mammograms May Not Boost Survival, Danish Study Suggests 3Health News:Your Posture Can Make or Break Your Job Interview; PostureNOW Offers 33% Off Its Posture Corrective Brace to Job Seekers Nationwide 2Health News:Sino Veda Herbal Product Maker Goes Natural in Edmonton Research Park 2
(Date:6/19/2013)... 19, 2013 /PRNewswire-iReach/ -- Robert M. Bernstein, ... transplant procedures and founder of Bernstein Medical – ... ,Best Doctors, issue of New York Magazine for ... http://photos.prnewswire.com/prnh/20130619/CG34629 ) Dr. Bernstein earned ... his reputation as world-renowned hair restoration physician, through ...
(Date:6/19/2013)... 2013 Amgen is pleased to announce the nine ... Canada and Puerto Rico ... Award for Science Teaching Excellence (AASTE). Now in its 21st ... 12th grade level who have an outstanding ability to inspire ... a long-standing commitment to science education, Amgen established the teacher ...
(Date:6/19/2013)... YORK , June 19, 2013 A ... Research in Helmholtz Zentrum München, Germany ... between autoantibodies and the risk of developing type 1 ... possible preventions for the disease. The study, "Seroconversion to ... in Children," was published today in The Journal ...
Breaking Medicine Technology:Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 2Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 3Amgen Award For Science Teaching Excellence Honors Outstanding Teachers 2Amgen Award For Science Teaching Excellence Honors Outstanding Teachers 3New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 2New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 3
... 12, 2011 The TandemHeart circulatory support system has ... Medicare Administrative Contractor (MAC) serving over 1.3 million beneficiaries ... of the United States. "We are extremely ... of the TandemHeart system," said  Kraig McEwen, President and ...
... Endologix, Inc. (NASDAQ: ELGX ), developer and ... details relating to the release of its second quarter 2011 ... 2011 after the close of the market. Endologix ... at 5:00 p.m. ET / 2:00 p.m. PT to discuss ...
Cached Medicine Technology:TandemHeart Approved for Expanded Reimbursement 2Endologix to Report Second Quarter 2011 Financial Results on July 21, 2011 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: